We can’t show the full text here under this license.
Abstract
Changes in the gut microbiome are associated with the accumulation of amyloid beta in Alzheimer's disease.
- Gut dysbiosis may influence the development and progression of Alzheimer's disease.
- Increased amyloid beta deposition is linked to alterations in gut microbiome composition.
- Cognitive impairment could be related to changes in the gut microbiome.
- Metabolites produced by the gut microbiome may play a role in Alzheimer's disease pathology.
- Potential therapies include antibiotics, prebiotics, probiotics, fecal microbiota transplantation, and dietary interventions.
Simplified